HopeStage
Back to overview

Depression studies

Topics
More filters

Depression

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

7264studies shown
Showing 1,477-1,488 of 7,264
Drug study icon
CompletedACTRN12614001061628

Comparison of antidepressant drug alone versus antidepressant drug plus bright light therapy combination for severe major depressive disorder

Official study title

Comparison of the efficacy of venlafaxine alone versus venlafaxine plus bright light therapy combination for the treatment of severe major depressive disorder

This study has finished and is no longer accepting participants.

In Turkey
DepressionInterventional studyAges 18–65
Countries
Türkiye
Sponsor
Yuzuncu Yil University, Scientific Research Projects Office
Behavioral study icon
CompletedACTRN12612000251820

Diet as a therapeutic target in depression: A controlled study

Official study title

Efficacy of a dietary intervention versus a control condition for reducing depression in individuals with major depressive disorder after 3 and 6 months

This study has finished and is no longer accepting participants.

Location not clearly listed
DepressionInterventional studyAges 18+
Countries
Sponsor
Barwon Health
Behavioral study icon
CompletedACTRN12621000073808

Enhancing parenting skills for women at risk of perinatal depression in a low-resource setting: a controlled study of Triple P for Baby

Official study title

A randomised controlled trial of the effect of a positive parenting Program (Triple P for Baby) on maternal depressive symptoms in pregnant women in a low-resource setting

This study has finished and is no longer accepting participants.

In Kenya
DepressionInterventional studyAges 18–45
Countries
Kenya
Sponsor
The University of Queensland
Drug study icon
CompletedACTRN12613000256774

Escitalopram efficacy and tolerability in treatment resistant depression. an open study.

Official study title

The objective of this European multicentre study was to evaluate escitalopram efficacy and tolerability in a population which has been shown to have Treatment Resistant Depression (TRD) in a prospective open treatment phase with venlafaxine over a 6 week period at an adequate dose after non response to previous antidepressants

This study has finished and is no longer accepting participants.

In Austria
DepressionInterventional studyAges 18–80
Countries
France, Belgium, Austria, + 3 others
Sponsor
Lundbeck
Device study icon
CompletedACTRN12611000054910

Investigating Magnetic Seizure Therapy in Major Depressive Disorder.

Official study title

A randomised controlled trial of Magnetic Seizure Therapy for the treatment of Major Depressive Disorder

This study has finished and is no longer accepting participants.

In Australia
DepressionInterventional studyAges 18–75
Countries
Australia
Sponsor
Professor Paul Fitzgerald
Drug study icon
RecruitingEUCTR 2017-003074-14

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-center Study to Compare the Anti-Depressive Efficacy and Safety of Samyr¿ IM versus Placebo IM as an Enhancer Adjunctive to Ant...

This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.

Multiple locations, including Giulianova
DepressionHistorical research record
Countries
Italy
Sponsor
MYLAN INC.
Drug study icon
RecruitingEUCTR 2017-003073-33

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Compare the Anti-Depressive Efficacy and Safety of Samyr® Tablet versus Placebo Tablet on top of Adjunctive Ant...

This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.

Multiple locations, including Albese con Cassano - Como
DepressionHistorical research record
Countries
Italy
Sponsor
Mylan Inc.
Drug study icon
CompletedEUCTR 2021-003989-12

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Adjunctive NBI-1065845 in Adult Subjects With Major Depressive Disorder (MDD)

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria
DepressionHistorical research record
Countries
Bulgaria, Czechia, Poland, + 1 other
Sponsor
Neurocrine Biosciences, Inc.

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.